| 1 |
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann, David S. Knopman, Howard Mark Chertkow et al. · Alzheimer s & Dementia
Open access |
22 Apr 2011 |
19,132 |
| 2 |
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al. · Alzheimer s & Dementia
Open access |
Apr 2018 |
10,885 |
| 3 |
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert, Steven T. DeKosky, Dennis W. Dickson et al. · Alzheimer s & Dementia
Open access |
22 Apr 2011 |
10,419 |
| 4 |
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa Anne Sperling et al. · Alzheimer s & Dementia
Open access |
22 Apr 2011 |
7,286 |
| 5 |
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Brian W. Kunkle et al. · Nature Genetics
ReviewOpen access469 authors |
28 Feb 2019 |
3,277 |
| 6 |
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
Bradley T. Hyman, Creighton H. Phelps, Thomas G. Beach et al. · Alzheimer s & Dementia
Open access |
2012 |
3,246 |
| 7 |
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Clifford R. Jack, Jeffrey Scott Andrews, Thomas G. Beach et al. · Alzheimer s & Dementia
Open access |
27 Jun 2024 |
2,670 |
| 8 |
Introduction to the recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Clifford R. Jack, Marilyn Albert, David S. Knopman et al. · Alzheimer s & Dementia
Open access |
22 Apr 2011 |
2,073 |
| 9 |
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
Adam Christian Naj et al. · Nature Genetics
Open access155 authors |
3 Apr 2011 |
2,024 |
| 10 |
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
Bruno Dubois et al. · Alzheimer s & Dementia
Open access |
Mar 2016 |
1,953 |
| 11 |
Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population‐based perspective
Matthew Baumgart, Heather M. Snyder, María C. Carrillo et al. · Alzheimer s & Dementia
Open access |
31 May 2015 |
1,696 |
| 12 |
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
Willemijn J. Jansen et al. · JAMA
Open access129 authors |
19 May 2015 |
1,662 |
| 13 |
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
Sebastian Palmqvist et al. · JAMA
Open access |
28 Jul 2020 |
1,657 |
| 14 |
Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
Yasser Iturria‐Medina et al. · Nature Communications
Open access316 authors |
21 Jun 2016 |
1,244 |
| 15 |
Neuropsychiatric symptoms in Alzheimer's disease
Constantine G. Lyketsos, María C. Carrillo, J. Michael Ryan et al. · Alzheimer s & Dementia
Open access |
Sep 2011 |
1,159 |
| 16 |
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
Rebecca C. Sims et al. · Nature Genetics
Open access450 authors |
17 Jul 2017 |
1,122 |
| 17 |
Nonpharmacological Therapies in Alzheimer’s Disease: A Systematic Review of Efficacy
Javier Olazarán et al. · Dementia and Geriatric Cognitive Disorders
Review |
2010 |
940 |
| 18 |
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
Tanayott Thaweethai et al. · JAMA
Open access825 authors |
25 May 2023 |
881 |
| 19 |
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
Reisa Anne Sperling, Clifford R. Jack, Sandra E. Black et al. · Alzheimer s & Dementia
Open access |
Jul 2011 |
859 |
| 20 |
Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
Eric M. Reiman, Kewei Chen, Xiaofen Liu et al. · Proceedings of the National Academy of Sciences
Open access |
3 Apr 2009 |
804 |
| 21 |
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI
Susan M. Landau, Danielle Jenine Harvey, Cindee M. Madison et al. · Neurobiology of Aging
Open access |
6 Aug 2009 |
775 |
| 22 |
Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus
Ben Readhead, Jean‐Vianney Haure‐Mirande, Cory C. Funk et al. · Neuron
Open access |
21 Jun 2018 |
746 |
| 23 |
New insights into atypical Alzheimer's disease in the era of biomarkers
Jonathan Graff‐Radford, Keir X. X. Yong, Liana G. Apostolova et al. · The Lancet Neurology
Open access |
18 Feb 2021 |
701 |
| 24 |
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease
Michael F. Egan, James T. Kost, Pierre N. Tariot et al. · New England Journal of Medicine
Open access |
2 May 2018 |
701 |
| 25 |
Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia
Gil D. Rabinovici, Constantine A. Gatsonis, Charles S. Apgar et al. · JAMA
Open access |
2 Apr 2019 |
686 |
| 26 |
Prevalence of Amyloid PET Positivity in Dementia Syndromes
Rik Ossenkoppele et al. · JAMA
Open access |
19 May 2015 |
682 |
| 27 |
Consensus classification of posterior cortical atrophy
Sebastian James Crutch et al. · Alzheimer s & Dementia
Open access |
Mar 2017 |
679 |
| 28 |
The Fundamentals of Person-Centered Care for Individuals With Dementia
Sam Fazio, Douglas D. Pace, Janice Flinner et al. · The Gerontologist
Open access |
12 Sep 2017 |
673 |
| 29 |
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
Giovanni Battista Frisoni et al. · The Lancet Neurology
Open access |
11 Jul 2017 |
646 |
| 30 |
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease
Oskar Hansson, Rebecca M. Edelmayer, Adam L. Boxer et al. · Alzheimer s & Dementia
Open access |
31 Jul 2022 |
626 |
| 31 |
Vascular contributions to cognitive impairment and dementia including Alzheimer's disease
Heather M. Snyder, Roderick A. Corriveau, Suzanne Craft et al. · Alzheimer s & Dementia
Open access |
12 Dec 2014 |
624 |
| 32 |
Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report
Joseph F. Arboleda‐Velásquez et al. · Nature Medicine
Open access |
Nov 2019 |
621 |
| 33 |
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions
Vivianna M. Van Deerlin et al. · Nature Genetics
Open access100 authors |
14 Feb 2010 |
618 |
| 34 |
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference
Alexandra L. Young et al. · Nature Communications
Open access380 authors |
9 Oct 2018 |
613 |
| 35 |
Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
Keith A. Johnson, Satoshi Minoshima, Nicolaas Ida Bohnen et al. · Alzheimer s & Dementia
Open access |
2013 |
609 |
| 36 |
Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons
Winnie S. Liang, Eric M. Reiman, Jon Valla et al. · Proceedings of the National Academy of Sciences
Open access |
10 Mar 2008 |
598 |
| 37 |
Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting
Cyndy B. Cordell, Soo Borson, Malaz A. Boustani et al. · Alzheimer s & Dementia
Open access |
20 Dec 2012 |
590 |
| 38 |
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
Jacob W. Vogel et al. · Nature Communications
Open access359 authors |
26 May 2020 |
568 |
| 39 |
Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease
Michael F. Egan, James T. Kost, Tiffini Voss et al. · New England Journal of Medicine
Open access |
10 Apr 2019 |
561 |
| 40 |
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study
Eric M. Reiman et al. · The Lancet Neurology
Open access |
5 Nov 2012 |
560 |
| 41 |
World‐Wide FINGERS Network: A global approach to risk reduction and prevention of dementia
Miia Kivipelto et al. · Alzheimer s & Dementia
Open access |
Jul 2020 |
552 |
| 42 |
Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need
Ganesh Muneshwar Babulal et al. · Alzheimer s & Dementia
Open access |
13 Dec 2018 |
551 |
| 43 |
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core
William J. Jagust, Dan Bandy, Kewei Chen et al. · Alzheimer s & Dementia
Open access |
May 2010 |
546 |
| 44 |
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
Gaël Chételat et al. · The Lancet Neurology
Open access |
21 Oct 2020 |
545 |
| 45 |
APOE4/4 is linked to damaging lipid droplets in Alzheimer’s disease microglia
Michael Seamus Haney et al. · Nature
Open access |
13 Mar 2024 |
532 |
| 46 |
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study
Eric M. Reiman et al. · Nature Communications
Open access192 authors |
3 Feb 2020 |
513 |
| 47 |
A survey of genetic human cortical gene expression
Amanda L. Myers et al. · Nature Genetics
|
4 Nov 2007 |
493 |
| 48 |
GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers
Eric M. Reiman et al. · Neuron
Open access |
Jun 2007 |
486 |
| 49 |
Contribution of chronic diseases to disability in elderly people in countries with low and middle incomes: a 10/66 Dementia Research Group population-based survey
Renata Sousa, Cleusa P. Ferri, Daisy Acosta et al. · The Lancet
Open access |
Nov 2009 |
482 |
| 50 |
Positron Emission Tomography Imaging With [ 18 F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes
Adam Fleisher et al. · JAMA Neurology
Open access |
27 Apr 2020 |
462 |